REFERENCES
- Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996; 49: 314–326
- Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000; 11: 1553–1561
- Abassi ZA, Hoffman A, Better OS. Acute renal failure complicating muscle crush injury. Semin Nephrol. 1998; 18: 558–565
- Ustundag S, Yalcin O, Sen S, Cukur Z, Ciftci S, Demirkan B. Ren Fail. 2008; 30: 727–735
- Stefanovic V, Savic V, Vlahovic P, Cvetkovic T, Najman S, Mitic-Zlatkovic M. Reversal of experimental myoglobinuric acute renal failure with bioflavonoids from seeds of grape. Ren Fail. 2000; 22: 255–266
- Chander V, Chopra K. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim Biophys Acta. 2005; 1723: 208–214
- Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984; 74: 1156–1164
- Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001; 55: 333–339
- Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34: 474–480
- Galaris D, Korantzopoulos P. On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med. 1997; 22: 657–667
- Di Lisa F, Barbato R, Manebo R, Siliprandi N. Carnitine and carnitine esters in mitochondrial metabolism and function. The carnitine system. A new therapeutical approach to cardiovascular diseases, JW De Jong, R Ferrari. Kluwer Academic Publishers, Dordrecth 1995; 21–38
- Mayes PA. Lipids of physiologic significance. Harper's Biochemistry, RK Murray, DK Granner, PA Mayes, VW Rodwell. Stamford, Appleton and Lange 2000; 160–171
- Arduini A. Carnitine and its acyl esters as secondary antioxidants?. Am Heart J. 1992; 123: 1726–1727
- Gülç I. Antioxidant and antiradical activities of L-carnitine. Life Sci. 2006; 78: 803–811
- Sener G, Ekşioğlu-Demiralp E, Cetiner M, et al. L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006; 22: 47–60
- Boonsanit D, Kanchanapangka S, Buranakarl C. L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats. Nephrology. 2006; 11: 313–320
- Origlia N, Migliori M, Panichi V, et al. Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. Biomed Pharmacother. 2006; 60: 77–81
- Görür S, Bağdatoğlu OT, Polat G. Protective effect of L-carnitine on renal ischaemia-reperfusion injury in the rat. Cell Biochem Funct. 2005; 23: 151–155
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351–358
- Aebi H. Catalase in vitro. Methods Enzymol. 1984; 105: 121–126
- Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol. 1988; 255: F438–F443
- McHowat J, Yamada KA, Saffitz JE, Corr PB. Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes. Cardiovasc Res. 1993; 27: 1237–1243
- Vanella A, Russo A, Acquaviva R, et al. L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol. 2000; 16: 99–104
- Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250: H822–H827
- Valdivielso JM, López-Novoa JM, Eleno N, Pérez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol. 2000; 78: 476–482
- Alvarez de Sotomayor M, Bueno R, Pérez-Guerrero C, Herrera MD. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. J Vasc Res. 2007; 44: 354–364
- Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol. 1988; 255: F539–F544
- Calò LA, Davis PA, Pagnin E, et al. Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: Studies in humans and in an animal model. Nephrol Dial Transplant. 2008; 23: 890–895
- Sever MS. The basic concepts. The crush syndrome, MS Sever. Karger, Basel 2005; 15–35
- Rosenberger C, Goldfarb M, Shina A, et al. Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transplant. 2008; 23: 1135–1143
- Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 2003; 42: 941–967
- Bain MA, Faull R, Milne RW, Evans AM. Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006; 7: 811–816
- Reuter SE, Faull RJ, Evans AM. L-carnitine supplementation in the dialysis population: Are Australian patients missing out?. Nephrology (Carlton). 2008; 13: 3–16
- Ohshima H, Kawabata T. Mechanism of N-nitrosodimethylamine formation from trimethylamine and trimethylaminoxide. IARC Sci Publ. 1978; 19: 143–153
- Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. N Engl J Med. 1977; 297: 132–135
- Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004; 1033: 30–41
- Moretti S, Alesse E, Di Marzio L, et al. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: A pilot study. Blood. 1998; 91: 3817–3824
- Moretti S, Famularo G, Marcellini S, et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal. 2002; 4: 391–403